Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study

BACKGROUND: Emerging data in chronic kidney disease (CKD) patients suggest that iron deficiency and higher circulating levels of erythropoietin (EPO) stimulate the expression and concomitant cleavage of the osteocyte-derived, phosphate-regulating hormone fibroblast growth factor 23 (FGF23), a risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenga, Michele F., De Jong, Maarten A., Van der Meer, Peter, Leaf, David E., Huls, Gerwin, Nolte, Ilja M., Gaillard, Carlo A. J. M., Bakker, Stephan J. L., De Borst, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553711/
https://www.ncbi.nlm.nih.gov/pubmed/31170159
http://dx.doi.org/10.1371/journal.pmed.1002818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553711/
https://www.ncbi.nlm.nih.gov/pubmed/31170159
http://dx.doi.org/10.1371/journal.pmed.1002818

Ejemplares similares